NDC 85477-0903-30: Nutralyn Multivitamin 20 mg; .15 mg; 26 mg; .3 mg; 60 mg; .1 mg; .28 mg; 1.67 mg; .013 mg; 80 mg Tablet, Bottle of 30
This is a package of 30 tablets of Nutralyn Multivitamin 20 mg; .15 mg; 26 mg; .3 mg; 60 mg; .1 mg; .28 mg; 1.67 mg; .013 mg; 80 mg Tablet from Oncora Pharma, LLC, first listed with the FDA Feb 2025 and currently FDA-listed. It is this product's only package size.
NDC database record
One package, one record: these facts belong to NDC 85477-903-30 alone.
- Record
- FDA NDC Directory package listing · Human prescription drug
- Code segments
- 85477 labeler · 903 product · 30 package
- Package marketed since
- Feb 24, 2025
- Sample package
- No — commercial package
- Listing certified through
- Dec 31, 2027
- Billing quantity
- 30 EA per package
- Barcode (UPC-A, from the NDC)
- 3 8547790330 7
- Medicaid fills, this package
- 1,353 prescriptions in the last four reported quarters
- FDA record last changed
- Nov 19, 2026
Identity & classification
Regulatory identifiers FDA, NLM and CMS codes for this package
Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification
- GSN (GCN sequence number): 081499
- GCN: 48633
- GPI-14 (Medi-Span): 78310000000300
- HICL (First Databank): 046846
- AHFS class code: 20:04.04.00
Where does this data come from?
- FDA openFDA NDC Directory · synced Nov 19, 2026
- FDA label on DailyMed · label index refreshed Nov 21, 2026
- RxNorm (NLM RxNav) · catalog refreshed Nov 19, 2026
- Medi-Span GPI (licensed)
- First Databank (licensed) · refreshed Nov 19, 2026
Clinical
Nutralyn Multivitamin is an oral tablet containing a combination of vitamins and minerals. The product includes vitamin C, vitamin D, vitamin B12, and other B vitamins (biotin, folic acid, and pyridoxine) that are typically used to support general nutritional intake. It also contains minerals such as calcium, magnesium, iron, and iodine, along with beta carotene and vitamin E acetate, which are commonly found in multivitamin formulations. This product is marketed without an approved FDA application.
Patient education
Supplement & herbal interactions
Where does this data come from?
- MedlinePlus (NLM) · refreshed Nov 19, 2026
- FDA label on DailyMed · label index refreshed Nov 21, 2026
Ask a licensed pharmacist directly — free, answered by our team.
Pricing
A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.
| Price system | Per each | Per package |
|---|---|---|
| Retail pharmacies payNADAC · weekly | Not in the retail survey — common for institutional, discontinued, or low-volume packs. | |
| Medicaid paysCMS SDUD · 12 mo | $53.01 | $1,590.39 / 30 tablets |
| Medicare drug plans payPart D · quarterly | No Part D plan price is available for this NDC in our data. | |
Where does this data come from?
- CMS NADAC weekly file
- CMS ASP pricing files · refreshed Nov 20, 2026
- CMS Medicaid State Drug Utilization Data · through Q1 2026
- CMS Part D plan pricing files · refreshed Oct 24, 2026
- VA National Acquisition Center price file
Packaging — all sizes for this product
| Package NDC | Description | Marketing start | Marketing end | Status |
|---|---|---|---|---|
| 85477-0903-30 You're viewing this Main listing | 30 TABLET in 1 BOTTLE | 2025-02-24 | — | Active |
Therapeutic equivalents
| Product | Labeler | Pack | NADAC/unit | TE | Status | Price vs. this |
|---|---|---|---|---|---|---|
| Aflora 20 mg/1; .15 mg/1; 26 mg/1; .3 mg/1; 60 mg/1; .1 mg/1; .28 mg/1; 1.67 mg/1; .013 mg/1; 80 mg 85477-0904-30 | Oncora | 30 tablets | — | — | FDA listed | — |
| Folixia 20 mg/1; .15 mg/1; 26 mg/1; .3 mg/1; 60 mg/1; .1 mg/1; .28 mg/1; 1.67 mg/1; .013 mg/1; 80 mg 85477-0902-30 | Oncora | 30 tablets | — | — | FDA listed | — |
| Nutralyn 20 mg/1; .15 mg/1; 26 mg/1; .3 mg/1; 60 mg/1; .1 mg/1; .28 mg/1; 1.67 mg/1; .013 mg/1; 80 mgthis 85477-0903-30 | Oncora | 30 tablets | — | — | FDA listed | — |
| Folivex 20 mg/1; .15 mg/1; 26 mg/1; .3 mg/1; 60 mg/1; .1 mg/1; .28 mg/1; 1.67 mg/1; .013 mg/1; 80 mg 85477-0906-30 | Oncora | 30 tablets | — | — | FDA listed | — |
Where does this data come from?
- FDA openFDA NDC Directory · synced Nov 19, 2026
- FDA Orange Book · refreshed Nov 6, 2026
- CMS NADAC weekly file
Availability & generic status
We did not find an FDA-approved generic match for this exact strength, form and route.
Where does this data come from?
- FDA Orange Book · refreshed Nov 6, 2026
What it looks like
Where does this data come from?
- FDA label on DailyMed · label index refreshed Nov 21, 2026
Inactive Ingredients / Excipients
Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.
💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.
-
UNII OP1R32D61U
Microcrystalline cellulose is a purified form of cellulose, a natural fiber from plant sources. It acts as a binder and filler in tablets and capsules, helping hold ingredients together and give the medicine its shape and size.
-
UNII M28OL1HH48
Croscarmellose sodium is a plant-based substance derived from cellulose. It acts as a disintegrant, helping tablets and capsules break down quickly in the digestive system so the medicine can be absorbed.
-
UNII 70097M6I30
Magnesium stearate is a salt made from magnesium and stearic acid, a fatty substance. It's used in tablets and capsules as a lubricant and glidant to help ingredients flow smoothly during manufacturing and prevent sticking.
-
UNII 7CVR7L4A2D
A starch-derived carbohydrate produced by breaking down corn, potato, or tapioca starch. It functions as a filler and binder to give the medicine bulk and texture, and sometimes as a mild sweetener or texture enhancer in powders and tablets.
-
UNII ETJ7Z6XBU4
Silicon dioxide is a naturally occurring mineral used as a glidant and anti-caking agent. It helps powder ingredients flow smoothly and prevents clumping during manufacturing and storage.
-
UNII 4ELV7Z65AP
Stearic acid is a fatty acid derived from plant or animal sources. It acts as a binder and lubricant in tablets and capsules, helping them hold together and flow smoothly during manufacturing.
6 inactive ingredients listed in the exact product block matched to this NDC.
Where does this data come from?
ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.- FDA label on DailyMed · label index refreshed Nov 21, 2026
- FDA openFDA NDC Directory · synced Nov 19, 2026
Inactive ingredient FAQ
Are inactive ingredients the same for every manufacturer?
Why might an inactive ingredient be missing?
Can inactive ingredients matter?
Manufacturer & labeler
More NDCs from Oncora Pharma, LLC labeler code 85477
- Probentra Probiotic Dietary Supplement Capsules 14 400 mg; 400 mg; 400 mg; 400 mg; 30 mg; 12 mg Capsule NDC 85477-712-30
- LidexaGel 5% Lidocaine HCl 50 mg/g Gel NDC 85477-730-07
- Lidoryx 5% Lidocaine HCl 50 mg/g Gel NDC 85477-731-07
- Folvyris Folate, Vitamin D3 1.7 mg; .125 mg Tablet NDC 85477-823-30
- Folaten Multivitamin 300 ug; 60 mg; 10 ug; 4.5 mg; 26 mg; .28 mg; 1.67 mg; .013 mg; 80 mg Tablet NDC 85477-901-30
- Folixia Multivitamin 20 mg; .15 mg; 26 mg; .3 mg; 60 mg; .1 mg; .28 mg; 1.67 mg; .013 mg; 80 mg Tablet NDC 85477-902-30
- Aflora Multivitamin 20 mg; .15 mg; 26 mg; .3 mg; 60 mg; .1 mg; .28 mg; 1.67 mg; .013 mg; 80 mg Tablet NDC 85477-904-30
- Urea 41% 410 mg/g Cream NDC 85477-905-30
- Folivex Multivitamin 20 mg; .15 mg; 26 mg; .3 mg; 60 mg; .1 mg; .28 mg; 1.67 mg; .013 mg; 80 mg Tablet NDC 85477-906-30
- DERMACURE Urea 41% 410 mg/g Cream NDC 85477-909-30
- Dermoyrx Urea 41% 410 mg/g Cream NDC 85477-910-30
- Foltira Folate, Vitamin D3 1.7 mg; .125 mg Tablet NDC 85477-921-30
Where does this data come from?
- FDA openFDA NDC Directory · synced Nov 19, 2026
- Drugs@FDA
Full prescribing information FDA SPL
🎯 Indications and Usage ▾
Nutralyn is a prescription multivitamin/multi-mineral dietary supplement formulated for the clinical dietary management of a subuoptimal nutritional status in patients where advanced folate, vitamin B supplementation, and maintenance of good health is needed.
⏱️ Dosage and Administration ▾
One tablet daily or as directed by a physician.
⛔ Contraindications ▾
Nutralyn is contraindicated in patients with a known hypersensitivity to any of the ingredients.
⚠️ Warnings ▾
WARNING Accidental overdose of iron-containing products is a leading cause of fatal poising in children under 6. Keep this product out of the reach of children. In the case of accidental overdose, call a doctor or poison control center immediately.
🤒 Adverse Reactions ▾
Allergic sensitization has been reported following both oral and parenteral administration of folic acid. You should call your doctor for medical advice about serious adverse events. To reports adverse side effects or to obtain product information, contact Oncora Pharma at 888-321-2821.
📦 How Supplied / Storage and Handling ▾
Bottles of 30 Tablets (85477-903-30). Tablet is light blue, oblong.
📦 Storage and Handling ▾
STORAGE: Store at 20- 25 degree C (68-77 F) excersions permitted to 15-30 degree C (59-86 F) {See USP controlled Room Temperature} Avoid excessive heat, light and moisture. TAMPER EVIDENT: Do not use if seal is broken or missing. MADE IN USA Distributed by: 888-321-2821 Oncora Pharma Dallas, TX 75161
📋 Description ▾
Nutralyn is a prescription multivitamin/multimineral dietary supplement.
📄 Other Information ▾
KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN
⚠️ Precautions ▾
Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where Vitamin B 12 deficient. Folic acid in doses above 1.0 mg daily may obscure pernicious anemia in that hematologic remission can occur while neurological manifestations progress.
📄 Package Label / Principal Display Panel ▾
label
Medicaid utilization & spend
Reported adverse events (FAERS)
Top reported reactions
Age at onset
Reporter sex
Serious outcomes
Where does this data come from?
About this NDC listing & data coverage
Listed without an FDA application
This product's marketing category indicates it is marketed without an approved FDA application (no NDA, ANDA, or BLA on file). Having an NDC does not by itself establish FDA approval — the NDC Directory is a listing system, not an approval decision. Approval-linked data such as Orange Book therapeutic-equivalence ratings therefore does not apply.
What data is (and isn’t) available for this NDC — tap to expand
| NDC identity (package / product / labeler codes) | ✓ Available |
| Labeler | ✓ Available |
| Product & package description | ✓ Available |
| Marketing category & status | ✓ Available |
| Active ingredient / dosage form / route | ✓ Available |
| FDA label (SPL via DailyMed) | ✓ Available |
| Package photos | ✓ Available |
| Inactive ingredients (structured) | ✓ Available |
| NADAC pharmacy acquisition price (CMS) | — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey. |
| Orange Book / therapeutic-equivalence data | — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope. |
| HCPCS J-code billing crosswalk | — Not published for this NDC Most self-administered / retail products have no J-code — that is normal. |
| Medicaid utilization (CMS SDUD) | ✓ Available |